DV
Dividend Vision

ZYBT — Zhengye Biotechnology Holding Limited Ordinary Shares

Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT)

Total return is -67.9% over the past 1.6 years, 102.0 points behind SPY at 34.1%. Its deepest 1-year drawdown was 94.9%.

This fund holds ordinary shares of Zhengye Biotechnology Holding Limited, providing direct equity exposure to a biotechnology company. The fund lacks publicly available distribution data and expense ratio information, suggesting it may be newly launched or thinly traded. This equity holding appeals primarily to growth-oriented investors seeking exposure to the biotechnology sector rather than income-focused investors.

ZYBT key facts

Asset type
Stock
Asset class
Equity
Inception date
01/07/2025
Last close
$1.56
Market cap
$379,604,928
Average volume
176600.0
Payout ratio
0.0
Forward P/E
0.0
EPS
$-1.76